Skip to main content
Market intelligence
OTLKHealthcare

Outlook Therapeutics Inc insider activity

In the last 90 days, 8 corporate insiders purchased $15,367,771 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$15,367,771
Corporate buyers
8
Latest transaction
Aug 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 14, 2026Lawrence A KenyonChief Financial OfficerOpen Market Purchase101,010$0.00$0.00
Aug 14, 2026Robert Charles JahrChief Executive OfficerOpen Market Purchase151,515$0.00$0.00
Aug 12, 2026Ghiath M. SukhtianDirector / 10% OwnerOpen Market Purchase2,525,252$0.99$2,499,999